Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-12

FDA Approved: BIORPHEN — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for BIORPHEN (phenylephrine hydrochloride) from Dr. Reddy's Laboratories Inc., updating/adding labeling for this vasopre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIORPHEN (phenylephrine hydrochloride)

Snippet

SUPPL AP for BIORPHEN (PHENYLEPHRINE HYDROCHLORIDE)